Therefore, herein we initially investigated the therapeutic efficacy of DPP4 inhibitors on multiple myeloma cells, work which subsequently led to the interesting findings indicating that DPP8 is a novel therapeutic target for multiple myeloma. This evidence concerns the gene DPP8 and AL amyloidosis.